Increased plasma arginase activity in human sepsis: association with increased circulating neutrophils
- 29 October 2013
- journal article
- research article
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 52 (4) , 573-581
Abstract
The pathophysiology of sepsis is incompletely understood. Impaired bioavailability of L-arginine, the substrate for NO synthesis, is linked to sepsis severity, and plasma arginase has been linked to hypoargininemia in other disease states. Circulating neutrophils are increased in sepsis and constitutively express arginase. We investigated whether plasma arginase activity is increased in human sepsis and whether this is associated with neutrophil numbers and activation. We used HPLC and a radiometric assay to evaluate plasma amino acid concentrations and plasma arginase activity. The relationships between plasma arginase activity, neutrophil count, neutrophil activity and plasma L-arginine and arginine metabolites were evaluated in 44 sepsis patients and 25 controls. Plasma arginase activity was increased in sepsis patients, correlated with neutrophil count (r=0.44; p=0.003), but was independent of sepsis severity (SOFA or APACHE II score). Plasma HNP1-3 correlated with neutrophil count (r=0.31; p=0.04), was elevated in shock (median 180 ng/mL vs. 83 ng/mL sepsis without shock, p=0.0006) and correlated with SOFA score. Sepsis patients with high neutrophil counts had significantly higher plasma HNP1-3 and arginase activity and lower plasma L-arginine concentrations than those with lower neutrophil counts and controls. Plasma arginase activity, potentially derived in part from neutrophil activation, is elevated in sepsis, and may contribute to impaired bioavailability of L-arginine in sepsis.Keywords
This publication has 44 references indexed in Scilit:
- Arginase Activity - A Marker of Disease Status in Patients with Visceral Leishmaniasis in EthiopiaPLOS Neglected Tropical Diseases, 2013
- Strategies for optimizing the serum persistence of engineered human arginase I for cancer therapyJournal of Controlled Release, 2012
- Ex-vivo changes in amino acid concentrations from blood stored at room temperature or on ice: implications for arginine and taurine measurementsBMC Clinical Pathology, 2009
- Sepsis-associated microvascular dysfunction measured by peripheral arterial tonometry: an observational studyCritical Care, 2009
- Recent advances in arginine metabolism: roles and regulation of the arginasesBritish Journal of Pharmacology, 2009
- Arginase I–Producing Myeloid-Derived Suppressor Cells in Renal Cell Carcinoma Are a Subpopulation of Activated GranulocytesCancer Research, 2009
- Resuscitating the Microcirculation in Sepsis: The Central Role of Nitric Oxide, Emerging Concepts for Novel Therapies, and Challenges for Clinical TrialsAcademic Emergency Medicine, 2008
- Impaired nitric oxide bioavailability and l-arginine–reversible endothelial dysfunction in adults with falciparum malariaJournal of Experimental Medicine, 2007
- Regulation of immune responses by L-arginine metabolismNature Reviews Immunology, 2005
- Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesisJournal of Clinical Investigation, 2003